Your browser doesn't support javascript.
loading
Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15-25 years: A phase IV randomized comparative study.
Folschweiller, Nicolas; Teixeira, Julio; Joshi, Smita; Goldani, Luciano Z; Supparatpinyo, Khuanchai; Basu, Partha; Chotpitayasunondh, Tawee; Chetchotisakd, Ploenchan; Ruxrungtham, Kiat; Roteli-Martins, Cecilia; Grinsztejn, Beatriz; Quintana, Silvana Maria; Kumarasamy, Nagalingeswaran; Poongulali, Selvamuthu; Kulkarni, Vinay; Lin, Lan; Datta, Sanjoy K; Descamps, Dominique; Dodet, Monique; Dubin, Gary; Friel, Damien; Hezareh, Marjan; Karkada, Naveen; Meric Camilleri, Dorothee; Poncelet, Sylviane; Salaun, Bruno; Tavares-da-Silva, Fernanda; Thomas-Jooris, Florence; Struyf, Frank.
Afiliação
  • Folschweiller N; GSK, Avenue Fleming 20, 1300 Wavre, Belgium.
  • Teixeira J; University of Campinas, Campinas, Brazil.
  • Joshi S; Jehangir Clinical Development Centre and Prayas, Pune, India.
  • Goldani LZ; Hospital de Clinicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre Brazil.
  • Supparatpinyo K; Chiang Mai University, Chiang Mai, Thailand.
  • Basu P; Chittaranjan National Cancer Institute, Kolkata, India.
  • Chotpitayasunondh T; Queen Sirikit National Institute of Child Health, Bangkok, Thailand.
  • Chetchotisakd P; Khon Kaen University, Khon Kaen, Thailand.
  • Ruxrungtham K; Chulalongkorn University and HIVNAT, TRC-ARC, Bangkok, Thailand.
  • Roteli-Martins C; ABC Medical School, Santo André, São Paulo, Brazil.
  • Grinsztejn B; Instituto de pesquisa Clínica Evandro Chagas (IPEC), Rio de Janeiro, Brazil.
  • Quintana SM; Ribeirão Preto Medical School, University of São Paulo (USP), São Paulo, Brazil.
  • Kumarasamy N; Infectious Diseases Medical Centre, Voluntary Health Services, Chennai, India.
  • Poongulali S; Infectious Diseases Medical Centre, Voluntary Health Services, Chennai, India.
  • Kulkarni V; Jehangir Clinical Development Centre and Prayas, Pune, India.
  • Lin L; GSK, Avenue Fleming 20, 1300 Wavre, Belgium.
  • Datta SK; GSK, Singapore, Singapore.
  • Descamps D; GSK, Avenue Fleming 20, 1300 Wavre, Belgium.
  • Dodet M; GSK, Rixensart, Belgium.
  • Dubin G; GSK, Avenue Fleming 20, 1300 Wavre, Belgium.
  • Friel D; GSK, Avenue Fleming 20, 1300 Wavre, Belgium.
  • Hezareh M; Chiltern international for GSK, Wavre, Belgium.
  • Karkada N; GSK, Avenue Fleming 20, 1300 Wavre, Belgium.
  • Meric Camilleri D; GSK, Avenue Fleming 20, 1300 Wavre, Belgium.
  • Poncelet S; GSK, Rixensart, Belgium.
  • Salaun B; GSK, Rixensart, Belgium.
  • Tavares-da-Silva F; GSK, Avenue Fleming 20, 1300 Wavre, Belgium.
  • Thomas-Jooris F; GSK, Avenue Fleming 20, 1300 Wavre, Belgium.
  • Struyf F; GSK, Avenue Fleming 20, 1300 Wavre, Belgium.
EClinicalMedicine ; 23: 100353, 2020 Jun.
Article em En | MEDLINE | ID: mdl-32639485
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: EClinicalMedicine Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Bélgica
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: EClinicalMedicine Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Bélgica